Bayshore Medical Center, formerly known as Bayshore Community Hospital, is a 169-bed general medical and surgical hospital located on a 37-acre campus at 727 North Beers Street, in Holmdel Township, New Jersey, United States, near the Raritan Bayshore.

There are 169 beds in Bayshore Community Hospital.

During the past decade, Bayshore Community Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bayshore Community Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "Rutgers, The State University of New Jersey" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bayshore Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Rutgers Cancer Institute of New Jersey" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Bayshore Community Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (3 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Breast Carcinoma" (2 trials), "Lung Carcinoma" (2 trials) and "ALK Gene Rearrangement" (1 trials). Many other conditions were trialed in "Bayshore Community Hospital" in a lesser frequency.

Most popular intervention types in "Bayshore Community Hospital" are "Other" (12 trials), "Drug" (8 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Nivolumab" (5 trials), "Computed Tomography" (4 trials), "Clinical Observation" (3 trials) and "Crizotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bayshore Community Hospital" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Bayshore Community Hospital". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Bayshore Community Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bayshore Community Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".